Non-Melanoma Skin Cancer Equipment
-
Manufactured by Xoft, a subsidiary of iCAD, Inc.based in USA
treatment of NMSC is possible with skin eBx, a form of high dose rate, low energy radiation therapy delivered in minutes over a short series of office visits. While Mohs surgery is considered to be the standard of care for non-melanoma skin cancer (NMSC) treatment, for some patients, surgery is not an option or ...
-
based in USA
The SRT-100+™—a state-of-the art system that is transforming the lives of people coping with non-melanoma skin cancer and unsightly keloid scars has been developed by Sensus ...
-
Manufactured by Xoft, a subsidiary of iCAD, Inc.based in USA
Xoft offers patients and physicians a non-invasive alternative to surgery for non-melanoma skin cancer (NMSC) treatment. With the Xoft Axxent Electronic Brachytherapy (eBx) System, painless, scar-free treatment of NMSC is possible with skin eBx, a form of high dose rate, low energy radiation ...
-
Manufactured by Xoft, a subsidiary of iCAD, Inc.based in USA
treatment of NMSC is possible with skin eBx, a form of high dose rate, low energy radiation therapy delivered in minutes over a short series of office visits. While Mohs surgery is considered to be the standard of care for non-melanoma skin cancer (NMSC) treatment, for some patients, surgery is not an option or ...
-
based in USA
Healthcare’s SRT-100™ has been cleared by the U.S. Food and Drug Administration for the treatment of non-melanoma skin cancer and keloids. It is ideal for private dermatology and oncology practices, as well as hospitals and multi-locale healthcare ...
-
Manufactured by Xoft, a subsidiary of iCAD, Inc.based in USA
The versatile Xoft Axxent® Electronic Brachytherapy (eBx) System utilizes breakthrough electronic brachytherapy technology to provide expanded treatment options for a range of cancers. With the Axxent controller, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing ...
-
Manufactured by Xoft, a subsidiary of iCAD, Inc.based in USA
Our proprietary, miniaturized x-ray source is isotope-free and operates at 50 kV to deliver high dose rate, low energy radiation. The source is placed inside the applicator and energized to deliver a precise, prescribed dose of radiation. With the Xoft System, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy ...
-
Manufactured by Xoft, a subsidiary of iCAD, Inc.based in USA
The versatile Xoft Axxent Electronic Brachytherapy (eBx) System utilizes state-of-the-art 50kV x-ray technology to provide expanded treatment options for a range of cancers. The Xoft System provides isotope-free HDR therapeutic radiation of the disease target while sparing surrounding healthy ...
-
based in USA
Akrotome Molecular Probes Offer a Precisely-Targeted Intervention for Cancer Surgery. Achieving a surgical cure for cancer depends on “getting it all” – removing all diseased tissue from a patient. To meet this need, Akrotome has developed a family of quenched, substrate-based probes (qSBPs) that precisely target enzymes ...
-
based in USA
Built with all the same great features and remarkable efficacy that distinguish the original SRT-100™, the SRT-100 Vision™ delivers the precise, painless calibrated dose of Superficial Radiation Therapy patients and physicians expect, but offers additional features—most notably high-frequency ultrasound for imaging. The SRT-100 Vision™ offers physicians, institutions and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you